Alajos Par
Pecs, BA, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
The challenge of the age of hepatitis C virus elimination: why is HCV vaccination necessary?
Journal: Orvosi hetilap
Published: December 27, 2022
Non-alcoholic fatty liver disease and type 2 diabetes mellitus. I. Pathogenesis
Journal: Orvosi hetilap
Published: January 14, 2022
Non-alcoholic fatty liver disease and type 2 diabetes mellitus. II. Treatment
Journal: Orvosi hetilap
Published: January 14, 2022
Sarcopenia - 2021: Pathophysiology, diagnosis, therapy
Journal: Orvosi hetilap
Published: August 02, 2020
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C.
Journal: Clinical and experimental medicine
Published: December 12, 2019
Alcoholic liver disease: the roles of genetic-epigenetic factors and the effect of abstinence
Journal: Orvosi hetilap
Published: April 02, 2019
Three decades of the hepatitis C virus from the discovery to the potential global elimination: the success of translational researches
Journal: Orvosi hetilap
Published: March 20, 2018
Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017
Journal: Orvosi hetilap
Published: February 27, 2018
Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy.
Journal: Clinical and experimental hepatology
Published: November 09, 2017
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Journal: Scientific reports
Published: August 29, 2017
Last Updated: 09/26/2026